Caspase 3 in dying tumor cells mediates post-irradiation angiogenesis

Oncotarget

Volumn 6, Issue 32, 2015, Pages 32353-32367

  Feng, Xiao ^a   Tian, Ling ^a   Zhang, Zhengxiang ^a   Yu, Yang ^a   Cheng, Jin ^a   Gong, Yanping ^a   Li, Chuan Yuan ^b   Huang, Qian ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Angiogenesis; Caspase 3; Dying tumor cells; VEGF A; X irradiation

Indexed keywords

CASPASE 3; EPIDERMAL GROWTH FACTOR RECEPTOR KINASE INHIBITOR; KI 8751; PROTEIN KINASE B; RANIBIZUMAB; UNCLASSIFIED DRUG; VASCULOTROPIN A; ANGIOGENESIS INHIBITOR; CASP3 PROTEIN, HUMAN; CASPASE INHIBITOR;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CARCINOGENESIS; CELL MIGRATION; CELL PROLIFERATION; CELL SURVIVAL; COLORECTAL CANCER CELL LINE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INACTIVATION; ENZYME INHIBITION; ENZYME MECHANISM; ENZYME REGULATION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; POST IRRADIATION ANGIOGENESIS; PROTEIN FUNCTION; RADIATION DOSE; SIGNAL TRANSDUCTION; UMBILICAL VEIN ENDOTHELIAL CELL; ANIMAL; CELL MOTION; COCULTURE; COLORECTAL NEOPLASMS; DRUG EFFECTS; DRUG SCREENING; ENZYME ACTIVATION; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENETICS; HT-29 CELL LINE; METABOLISM; NEOVASCULARIZATION (PATHOLOGY); NUDE MOUSE; PARACRINE SIGNALING; PATHOLOGY; RADIATION RESPONSE; TIME FACTOR;

ANGIOGENESIS INHIBITORS; ANIMALS; APOPTOSIS; CASPASE 3; CASPASE INHIBITORS; CELL MOVEMENT; CELL PROLIFERATION; COCULTURE TECHNIQUES; COLORECTAL NEOPLASMS; ENZYME ACTIVATION; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HT29 CELLS; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; MALE; MICE, NUDE; NEOVASCULARIZATION, PATHOLOGIC; PARACRINE COMMUNICATION; SIGNAL TRANSDUCTION; TIME FACTORS; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84946017547     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.5898     Document Type: Article

References (51)

1. Prise KM, Schettino G, Folkard M and Held KD. New insights on cell death from radiation exposure. The Lancet Oncology. 2005; 6:520-528.
2. Garcia-Barros M, Paris F, Cordon-Cardo C, Lyden D, Rafii S, Haimovitz-Friedman A, Fuks Z and Kolesnick R. Tumor response to radiotherapy regulated by endothelial cell apoptosis. Science (New York, NY). 2003; 300:1155-1159.
3. Mao XW. A quantitative study of the effects of ionizing radiation on endothelial cells and capillary-like network formation. Technology in cancer research & treatment. 2006; 5:127-134.
4. Ahmad M, Khurana NR and Jaberi JE. Ionizing radiation decreases capillary-like structure formation by endothelial cells in vitro. Microvascular research. 2007; 73:14-19.
5. Tsai JH, Makonnen S, Feldman M, Sehgal CM, Maity A and Lee WM. Ionizing radiation inhibits tumor neovascularization by inducing ineffective angiogenesis. Cancer biology & therapy. 2005; 4:1395-1400.
6. Svagzdys S, Lesauskaite V, Pavalkis D, Nedzelskiene I, Pranys D and Tamelis A. Microvessel density as new prognostic marker after radiotherapy in rectal cancer. BMC cancer. 2009; 9:95.
7. Gorski DH, Beckett MA, Jaskowiak NT, Calvin DP, Mauceri HJ, Salloum RM, Seetharam S, Koons A, Hari DM, Kufe DW and Weichselbaum RR. Blockage of the vascular endothelial growth factor stress response increases the antitumor effects of ionizing radiation. Cancer research. 1999; 59:3374-3378.
8. Hovinga KE, Stalpers LJ, van Bree C, Donker M, VerhoeffJJ, Rodermond HM, Bosch DA and van Furth WR. Radiation-enhanced vascular endothelial growth factor (VEGF) secretion in glioblastoma multiforme cell lines-a clue to radioresistance? Journal of neuro-oncology. 2005; 74:99-103.
9. Chung YL, Jian JJ, Cheng SH, Tsai SY, Chuang VP, Soong T, Lin YM and Horng CF. Sublethal irradiation induces vascular endothelial growth factor and promotes growth of hepatoma cells: implications for radiotherapy of hepatocellular carcinoma. Clinical cancer research: an official journal of the American Association for Cancer Research. 2006; 12:2706-2715.
10. Jadhav U and Mohanam S. Response of neuroblastoma cells to ionizing radiation: modulation of in vitro invasiveness and angiogenesis of human microvascular endothelial cells. International journal of oncology. 2006; 29:1525-1531.
11. Brieger J, Schroeder P, Gosepath J and Mann WJ. The cyclooxygenase inhibitor flurbiprofen reduces radiationinduced angiogenic growth factor secretion of squamous cell carcinoma cell lines. Annals of the New York Academy of Sciences. 2004; 1030:37-42.
12. Parthymou A, Kardamakis D, Pavlopoulos I and Papadimitriou E. Irradiated C6 glioma cells induce angiogenesis in vivo and activate endothelial cells in vitro. International journal of cancer Journal international du cancer. 2004; 110:807-814.
13. Kaliski A, Maggiorella L, Cengel KA, Mathe D, Rouffiac V, Opolon P, Lassau N, Bourhis J and Deutsch E. Angiogenesis and tumor growth inhibition by a matrix metalloproteinase inhibitor targeting radiation-induced invasion. Molecular cancer therapeutics. 2005; 4:1717-1728.
14. Nojiri K, Iwakawa M, Ichikawa Y, Imadome K, Sakai M, Nakawatari M, Ishikawa K, Ishikawa A, Togo S, Tsujii H, Shimada H and Imai T. The proangiogenic factor ephrin-A1 is up-regulated in radioresistant murine tumor by irradiation. Experimental biology and medicine. 2009; 234:112-122.
15. Huang Q, Li F, Liu X, Li W, Shi W, Liu FF, O'Sullivan B, He Z, Peng Y, Tan AC, Zhou L, Shen J, Han G, Wang XJ, Thorburn J, Thorburn A, et al. Caspase 3-mediated stimulation of tumor cell repopulation during cancer radiotherapy. Nature medicine. 2011; 17:860-866.
16. Desai S, Kumar A, Laskar S and Pandey BN. Cytokine profile of conditioned medium from human tumor cell lines after acute and fractionated doses of gamma radiation and its effect on survival of bystander tumor cells. Cytokine. 2013; 61:54-62.
17. Hutchinson L. Radiotherapy: Repopulating tumor cells-dying for caspase 3. Nature reviews Clinical oncology. 2011; 8:508.
18. Hast J, Schiffer IB, Neugebauer B, Teichman E, Schreiber W, Brieger J, Kim DW, Gebhard S, Born CJ, Strugala M, Sagemuller J, Brenner W, Mann WJ, Oesch F, Thelen M and Hengstler JG. Angiogenesis and fibroblast proliferation precede formation of recurrent tumors after radiation therapy in nude mice. Anticancer research. 2002; 22:677-688.
19. Koukourakis MI, Giatromanolaki A, Sivridis E, Simopoulos K, Pissakas G, Gatter KC and Harris AL. Squamous cell head and neck cancer: evidence of angiogenic regeneration during radiotherapy. Anticancer research. 2001; 21:4301-4309.
20. Kozin SV, Duda DG, Munn LL and Jain RK. Neovascularization after irradiation: what is the source of newly formed vessels in recurring tumors? Journal of the National Cancer Institute. 2012; 104:899-905.
21. Asuthkar S, Velpula KK, Nalla AK, Gogineni VR, Gondi CS and Rao JS. Irradiation-induced angiogenesis is associated with an MMP-9-miR-494-syndecan-1 regulatory loop in medulloblastoma cells. Oncogene. 2014; 33:1922-1933.
22. Liu Y, Zhang L, Liu Y, Sun C, Zhang H, Miao G, Di CX, Zhou X, Zhou R and Wang Z. DNA-PKcs deficiency inhibits glioblastoma cell-derived angiogenesis after ionizing radiation. Journal of cellular physiology. 2015; 230:1094-1103.
23. Gottfarstein-Maruani A, Michenet P, Kerdraon R and Esteve E. Benign vascular proliferations in previously irradiated skin. The American journal of surgical pathology. 2002; 26:1372-1373.
24. Requena L, Kutzner H, Mentzel T, Duran R and RodriguezPeralto JL. Benign vascular proliferations in irradiated skin. The American journal of surgical pathology. 2002; 26:328-337.
25. Gengler C, Coindre JM, Leroux A, Trassard M, RanchereVince D, Valo I, Michels JJ and Guillou L. Vascular proliferations of the skin after radiation therapy for breast cancer: clinicopathologic analysis of a series in favor of a benign process: a study from the French Sarcoma Group. Cancer. 2007; 109:1584-1598.
26. Donato AL, Huang Q, Liu X, Li F, Zimmerman MA and Li CY. Caspase 3 promotes surviving melanoma tumor cell growth after cytotoxic therapy. The Journal of investigative dermatology. 2014; 134:1686-1692.
27. Cheng J, Tian L, Ma J, Gong Y, Zhang Z, Chen Z, Xu B, Xiong H, Li C and Huang Q. Dying tumor cells stimulate proliferation of living tumor cells via caspase-dependent protein kinase Cdelta activation in pancreatic ductal adenocarcinoma. Molecular oncology. 2015; 9:105-114.
28. Dimmeler S, Haendeler J, Nehls M and Zeiher AM. Suppression of apoptosis by nitric oxide via inhibition of interleukin-1beta-converting enzyme (ICE)-like and cysteine protease protein (CPP)-32-like proteases. The Journal of experimental medicine. 1997; 185:601-607.
29. Nicholson DW, Ali A, Thornberry NA, Vaillancourt JP, Ding CK, Gallant M, Gareau Y, Griffin PR, Labelle M, Lazebnik YA and et al. Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature. 1995; 376:37-43.
30. Kuraishy A, Karin M and Grivennikov SI. Tumor promotion via injury-and death-induced inflammation. Immunity. 2011; 35:467-477.
31. Povero D, Eguchi A, Niesman IR, Andronikou N, de Mollerat du Jeu X, Mulya A, Berk M, Lazic M, Thapaliya S, Parola M, Patel HH and Feldstein AE. Lipid-induced toxicity stimulates hepatocytes to release angiogenic microparticles that require Vanin-1 for uptake by endothelial cells. Science signaling. 2013; 6:ra88.
32. Kennedy OD, Laudier DM, Majeska RJ, Sun HB and Schaffler MB. Osteocyte apoptosis is required for production of osteoclastogenic signals following bone fatigue in vivo. Bone. 2014; 64:132-137.
33. Jiang BH and Liu LZ. AKT signaling in regulating angiogenesis. Current cancer drug targets. 2008; 8:19-26.
34. Laplante P, Sirois I, Raymond MA, Kokta V, Beliveau A, Prat A, Pshezhetsky AV and Hebert MJ. Caspase-3-mediated secretion of connective tissue growth factor by apoptotic endothelial cells promotes fibrosis. Cell death and differentiation. 2010; 17:291-303.
35. Li F, Huang Q, Chen J, Peng Y, Roop DR, Bedford JS and Li CY. Apoptotic cells activate the "phoenix rising" pathway to promote wound healing and tissue regeneration. Science signaling. 2010; 3:ra13.
36. Liu X, He Y, Li F, Huang Q, Kato TA, Hall RP and Li CY. Caspase-3 promotes genetic instability and carcinogenesis. Molecular cell. 2015; 58:284-296.
37. Emoto Y, Manome Y, Meinhardt G, Kisaki H, Kharbanda S, Robertson M, Ghayur T, Wong WW, Kamen R, Weichselbaum R and et al. Proteolytic activation of protein kinase C delta by an ICE-like protease in apoptotic cells. The EMBO journal. 1995; 14:6148-6156.
38. Koriyama H, Kouchi Z, Umeda T, Saido TC, Momoi T, Ishiura S and Suzuki K. Proteolytic activation of protein kinase C delta and epsilon by caspase-3 in U937 cells during chemotherapeutic agent-induced apoptosis. Cellular signalling. 1999; 11:831-838.
39. Carvour M, Song C, Kaul S, Anantharam V, Kanthasamy A and Kanthasamy A. Chronic low-dose oxidative stress induces caspase-3-dependent PKCdelta proteolytic activation and apoptosis in a cell culture model of dopaminergic neurodegeneration. Annals of the New York Academy of Sciences. 2008; 1139:197-205.
40. Kanthasamy AG, Kitazawa M, Yang Y, Anantharam V and Kanthasamy A. Environmental neurotoxin dieldrin induces apoptosis via caspase-3-dependent proteolytic activation of protein kinase C delta (PKCdelta): Implications for neurodegeneration in Parkinson's disease. Molecular brain. 2008; 1:12.
41. Kato K, Yamanouchi D, Esbona K, Kamiya K, Zhang F, Kent KC and Liu B. Caspase-mediated protein kinase C-delta cleavage is necessary for apoptosis of vascular smooth muscle cells. American journal of physiology Heart and circulatory physiology. 2009; 297:H2253-2261.
42. Choi YH, Jin GY, Li LC and Yan GH. Inhibition of protein kinase C delta attenuates allergic airway inflammation through suppression of PI3K/Akt/mTOR/HIF-1 alpha/VEGF pathway. PloS one. 2013; 8:e81773.
43. Kim KW, Moretti L and Lu B. M867, a novel selective inhibitor of caspase-3 enhances cell death and extends tumor growth delay in irradiated lung cancer models. PloS one. 2008; 3:e2275.
44. Blagosklonny MV. Antiangiogenic therapy and tumor progression. Cancer cell. 2004; 5:13-17.
45. Blagosklonny MV. How Avastin potentiates chemotherapeutic drugs: action and reaction in antiangiogenic therapy. Cancer biology & therapy. 2005; 4:1307-1310.
46. Wachsberger P, Burd R and Dicker AP. Tumor response to ionizing radiation combined with antiangiogenesis or vascular targeting agents: exploring mechanisms of interaction. Clinical cancer research: an official journal of the American Association for Cancer Research. 2003; 9:1957-1971.
47. Clemenson C, Chargari C and Deutsch E. Combination of vascular disrupting agents and ionizing radiation. Critical reviews in oncology/hematology. 2013; 86:143-160.
48. Shinohara ET, Cao C, Niermann K, Mu Y, Zeng F, Hallahan DE and Lu B. Enhanced radiation damage of tumor vasculature by mTOR inhibitors. Oncogene. 2005; 24:5414-5422.
49. Demidenko ZN and Blagosklonny MV. The purpose of the HIF-1/PHD feedback loop: to limit mTOR-induced HIF-1alpha. Cell cycle (Georgetown, Tex). 2011; 10:1557-1562.
50. Hu X, Zhang L, Jin J, Zhu W, Xu Y, Wu Y, Wang Y, Chen H, Webster KA, Chen H, Yu H and Wang J. Heparanase released from mesenchymal stem cells activates integrin beta1/HIF-2alpha/Flk-1 signaling and promotes endothelial cell migration and angiogenesis. Stem cells. 2015; 33:1850-1862.
51. Schmidt S, Liu G, Liu G, Yang W, Honisch S, Pantelakos S, Stournaras C, Honig A and Lang F. Enhanced Orai1 and STIM1 expression as well as store operated Ca2+ entry in therapy resistant ovary carcinoma cells. Oncotarget. 2014; 5:4799-4810.